A PHASE 3 STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF REVACCINATING PREGNANT PARTICIPANTS DURING SUBSEQUENT PREGNANCIES AND PERSISTENCE OF IMMUNITY OF A SINGLE DOSE OF A BIVALENT RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE
Clinical Trial Grant
Administered By
Obstetrics and Gynecology, Maternal Fetal Medicine
Awarded By
Pfizer, Inc.
Start Date
July 7, 2025
End Date
July 31, 2029
Administered By
Obstetrics and Gynecology, Maternal Fetal Medicine
Awarded By
Pfizer, Inc.
Start Date
July 7, 2025
End Date
July 31, 2029